Erratum

The July 15 Med Check column incorrectly reported that a study on atomoxetine (Strattera) by Humberto Quintana, M.D., of Louisiana State University found that children given the drug as a once-a-day evening dose were more likely to report adverse events than children taking the medication as a once-a-day morning dose. The study found the opposite: the percentage of children experiencing at least one adverse event was 74 percent with morning dosing, 48.9 percent with evening dosing, and 43.5 percent with placebo.▪